Dr. Mark B. Bromberg, MD, PhD

Dr. Bromberg practices at University of Utah Hospitals and Clinics - Unit in Salt Lake City, Utah.

Dr. Bromberg's NPI, 1164517009, was assigned on October 4, 2006. Dr. Bromberg graduated from University of Michigan Medical School in 1982. Dr. Bromberg holds Utah license 274745-1205.

Dr. Bromberg's primary practice is University of Utah Hospitals and Clinics - Unit, at 50 North Medical Drive, Salt Lake City, UT 84132 in Salt Lake County. The practice phone is (801) 581-2337.

Dr. Bromberg's primary practice is University of Utah Hospitals and Clinics - Unit in Salt Lake City, Utah. Dr. Bromberg is also affiliated with University of Utah Hospital. The medical group on file is University of Utah Health. Dmand AI also links Dr. Bromberg to 1 more hospital, 1 group practice or clinic, 1 skilled nursing facility and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bromberg practices, 5 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Bromberg's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dmand AI has Dr. Bromberg's licenses on file in 2 states: Utah and Wyoming.

CMS data shows 287 Medicare services from Dr. Bromberg across 4 procedure codes in 2024, for 144 Medicare patients. Medicare paid $17,471 for them.

CMS counts 144 Medicare patients who saw Dr. Bromberg in 2024. The largest group is 65 to 74, with 62 patients. 56% of them have high blood pressure, and 49% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.31, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Bromberg's median patient age at 72, with 44% women.

In 2024, Dr. Bromberg wrote 588 Medicare Part D claims for 94 patients. 88% of them were for generic drugs. CMS names the drug for 482 of them, across 19 drugs with 11 or more claims each, at $837,170 in total drug cost. In 2023, CMS named 398 claims across 16 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Bromberg for performance year 2024, reported as part of a group. Dr. Bromberg accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bromberg as offering telehealth.

Dmand AI links 56 papers to Dr. Bromberg, published from 2006 to 2025. 2023 was the busiest year, with 5. The most frequent topics are Amyotrophic Lateral Sclerosis, Disease Progression and Electromyography. Dr. Bromberg has published most often in Amyotroph Lateral Scler Frontotemporal Degener. Dr. Bromberg's most frequent co-authors are Summer Bell Gibson, MD, Tulio E. Bertorini, MD and Paul E. Barkhaus, MD.

CMS Open Payments shows 273 general payments to Dr. Bromberg from 17 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 52% of the total. Argenx US, Inc. paid the most, $139,936.

Dr. Bromberg graduated from University of Michigan Medical School in 1982.